Travere Therapeutics
TVTX
TVTX
128 hedge funds and large institutions have $1.21B invested in Travere Therapeutics in 2018 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 43 increasing their positions, 39 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
128
Holders Change
-1
Holders Change %
-0.78%
% of All Funds
2.93%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
17
Increased
43
Reduced
39
Closed
18
Calls
$14.6M
Puts
$9.99M
Net Calls
+$4.62M
Net Calls Change
-$3.97M
Top Buyers
| 1 |
Invesco
Atlanta,
Georgia
|
+$15.5M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$11.5M |
| 3 |
GTC
Ghost Tree Capital
New York
|
+$10.1M |
| 4 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$9.4M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$8.87M |
Top Sellers
| 1 |
Jennison Associates
New York
|
-$7.93M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$7.41M |
| 3 |
TCIM
TIAA CREF Investment Management
New York
|
-$5.85M |
| 4 |
BA
Boston Advisors
Boston,
Massachusetts
|
-$3.43M |
| 5 |
BC
Broadfin Capital
New York
|
-$3.17M |
